Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase III Study for Evaluating the Role of the Addition of Ovarian Function Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain in Premenopause or Regain Menstruation After Chemotherapy

NCT00912548 is registered in ClinicalTrials.gov with Korean Breast Cancer Study Group as lead sponsor.

NCT NCT00912548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00912548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase III Study for Evaluating the Role of the Addition of Ovarian Function Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain in Premenopause or Regain Menstruation After Chemotherapy
Lead sponsor
Korean Breast Cancer Study Group
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2009
Completion date
December 31, 2015
Enrollment
1,234 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer